This week, we celebrate with our GIS colleagues who were conferred various awards for their distinguished service and significant contributions to A*STAR and Singapore. Our heartiest congratulations to the following awardees!

Catch the National Stem Championship 2024 - Semi-finals 3 & 4 at 7:30PM tonight! With GIS being one of the hosts for the Semi-Finals, the students had a preview of the genomic sciences we do at GIS to crack the challenge for the day. Watch the trailer: facebook.com/watch/?v=49551…

Join us at the next National Precision Medicine Alliance (NPMA) with talks by Prof Christopher Chen, Dr Dr Jingmei Li and Dr Mohamed ElSayed on 26 Nov, 4pm. Register at a-star-engagementportal.glueup.com/event/national…

A fantastic talk by Dr. Dr Jingmei Li at the ENABLE conference, where she discussed how AI can be applied in mammography to address breast cancer.🫡

Next, Dr. Jingmei Li (Dr Jingmei Li) shared her scientific journey, using AI to personalize breast cancer detection. Her stories encouraged young researchers to embrace curiosity and create impactful solutions in medical research. #ENABLE2024

Absolutely true

Thanks to Dr Jingmei Li of A*STAR Research for joining our recent think tank in Singapore! 💡 At these think tanks, we're convening researchers and clinicians to discuss the most urgent issues in #CancerResearch, to help shape our next set of challenges (coming Mar '25) ⏳

Personalized breast cancer screening can save lives, but advice on reducing risk for high-risk women isn't consistent. Our review shows gaps in research from Asia and calls for more studies on prevention options such as breast cancer risk-reducing drugs. mdpi.com/3123568

Moderator for the event In Conversation with Eminent Scientists at the Science Centre Singapore!

Congratulations Jonathan Göke Dr Jingmei Li from A*STAR Genome Institute of Singapore (A*STAR GIS), recipients of the 2024 A*STAR Fellows for their outstanding contributions, leadership and impact on the local and international scientific community! 🏅🧪🧬💻

In collaboration with Saw Swee Hock School of Public Health, researchers from A*STAR Genome Institute of Singapore (A*STAR Genome Institute of Singapore (A*STAR GIS)) explored women’s preferences and their willingness to adopt tests to predict breast cancer risk. Using a discrete choice experiment with over 300

"Building a brighter tomorrow by planting the seeds of STEM today" with LEGO® Serious Play®.

True story. Reviewer 2 says see pdf with comments attached. I was seriously hit by a wave of nostalgia when I saw everything handwritten and scanned. 😄

Happy 0214!

This year International Women in STEMM Sg will be taking place in Academia! Sign up soon for a one day event, joining the panel discussions, breakout sessions and debates on actions to embrace #diversity in #STEMM! #IWD2025 linkedin.com/posts/internat…

Different ways of predicting breast cancer risk don’t always identify the same people. Patients may have a family history, high genetic risk, or other factors, but not always all at once. Relying on one method could miss some high-risk individuals. medrxiv.org/content/10.110…

Our new study looks at how women in Singapore really feel about risk-based screening (RBS) - what helps, what hinders, and what needs to change. frontiersin.org/journals/psych…

“I have a hot date!” = my go-to exit strategy for networking events that turn into hostage situations. That was my reply to a question on work-life balance at the National STEM Talent Search 2025. 😂

Previously known as A*STAR Talent, the National STEM Talent Search (NSTS) is an initiative launched in 2022 to recognize students who have excelled in scientific research. Shared at the fireside chat!

In our study of 4,112 women, 1 in 3 updated how they saw their breast cancer risk after learning their predicted score. Risk-based screening empowers women with personalized knowledge, but when perceived risk feels lower than predicted, confidence drops. > …nslational-medicine.biomedcentral.com/articles/10.11…